Merck, a pharmaceutical company based in Kenilworth, New Jersey, announced that its PD-1 inhibitor pembrolizumab subcutaneous injection has been approved……
Yiborui Releases AI Intelligent Agent Research Report: Consumer Willingness to Use Rises, Focus on “Authorization Management Mechanism”
Consumers are gradually applying AI intelligent agents to more complex financial service scenarios—beyond information retrieval and product comparison, more users……
Sino Group and SVhk Launch ‘Inno-North’ Initiative in Hong Kong
The northern urban area is gradually evolving into an important new community in Hong Kong’s future. With the ongoing development……
US Takes Stringent Approach in Regulating Chinese Automakers
Senator Bernie Moreno of Ohio revealed ongoing talks to modify a bill intending to intensify restrictions on Chinese vehicles trading……
China’s Gwadar Port in Pakistan: A Plan Unfulfilled
China’s ambitious port project in Pakistan at Gwadar faces challenges as it falls short of its promised potential. Gwadar was……
China’s New Measures to Boost Economy and Property Sector
China unveiled new measures to stimulate its economy and property sector, aiming to meet its year-end economic growth target. The……
Breakthroughs in Biotech: Key Updates and Potential Impact
In the realm of biotechnology, significant advances are being made that could potentially revolutionize the landscape of healthcare. Novo, a…
Breakthroughs in Biotech: Key Updates and Potential Impact comes from ChinaRetailNews.com. ChinaRetailNews.c……
Transport Corporation of India Announces ₹1,500 Crore Buyback and China Subsidiary
Transport Corporation of India has approved a share buyback worth ₹1,500 crore and the incorporation of a wholly owned subsidiary……
Hangzhou’s Tech Companies Forge Strong Ties with Hong Kong for Global Expansion
On September 22, the Hong Kong Industry Cooperation Promotion Conference & 9th Hangzhou-Hong Kong-Macao Development Exchange Conference 2026 brought together……
A Complete Guide To DeepSeek’s 2026 IPO: What It Means For China ETF KSTR
KSTR does not currently hold DeepSeek, and future index inclusion would depend entirely on where DeepSeek’s market cap ends up after listing….
-
-
Recent Updates
- Merck’s PD-1 Inhibitor Pembrolizumab Subcutaneous Injection Approved in China
- Yiborui Releases AI Intelligent Agent Research Report: Consumer Willingness to Use Rises, Focus on “Authorization Management Mechanism”
- Sino Group and SVhk Launch ‘Inno-North’ Initiative in Hong Kong
- US Takes Stringent Approach in Regulating Chinese Automakers
- China’s Gwadar Port in Pakistan: A Plan Unfulfilled
- China’s New Measures to Boost Economy and Property Sector
- Breakthroughs in Biotech: Key Updates and Potential Impact
- Transport Corporation of India Announces ₹1,500 Crore Buyback and China Subsidiary
- Hangzhou’s Tech Companies Forge Strong Ties with Hong Kong for Global Expansion
- A Complete Guide To DeepSeek’s 2026 IPO: What It Means For China ETF KSTR
Blogroll